Terms: = Breast cancer AND CEACAM5, CEA AND Prognosis
204 results:
1. Implications of Pretreatment Serum Carcinoembryonic Antigen Levels and Perineural Invasion with Staging, prognosis, and Management in Stage I-III Colon cancer after Surgery: A Retrospective Cohort Study in the SEER Database.
Zhang Q; Wang L; Sun R; Gao J; Liu T
Ann Ital Chir; 2024; 95(2):144-154. PubMed ID: 38684496
[TBL] [Abstract] [Full Text] [Related]
2. Clinical value of KiSS-1 and MMP-2 expression levels in breast cancer tissue in evaluating prognosis of elderly breast cancer patients after modified radical mastectomy.
Lv J; Zhang J; Wu F
Cell Mol Biol (Noisy-le-grand); 2024 Mar; 70(3):254-259. PubMed ID: 38650158
[TBL] [Abstract] [Full Text] [Related]
3. Potential Value of HSP90α in prognosis of Triple-Negative breast cancer.
Wang HF; Chen Y; Cao B; Pei J
Med Sci Monit; 2024 Mar; 30():e943049. PubMed ID: 38553816
[TBL] [Abstract] [Full Text] [Related]
4. sPD-L1 and sPD-L2 in plasma of patients with lung cancer and their clinical significance.
Han S; Zhang Y; Yuan J; Wu Y; Zhou Y; Zhou Y; Li X; Zhou S
Cytokine; 2024 Apr; 176():156532. PubMed ID: 38330638
[TBL] [Abstract] [Full Text] [Related]
5. The emerging roles of ceaCAM6 in human cancer (Review).
Wu G; Wang D; Xiong F; Wang Q; Liu W; Chen J; Chen Y
Int J Oncol; 2024 Mar; 64(3):. PubMed ID: 38240103
[TBL] [Abstract] [Full Text] [Related]
6. Machine learning-based models for the prediction of breast cancer recurrence risk.
Zuo D; Yang L; Jin Y; Qi H; Liu Y; Ren L
BMC Med Inform Decis Mak; 2023 Nov; 23(1):276. PubMed ID: 38031071
[TBL] [Abstract] [Full Text] [Related]
7. Dynamic analysis of circulating tumor DNA to predict the prognosis and monitor the treatment response of patients with metastatic triple-negative breast cancer: A prospective study.
Chi Y; Su M; Zhou D; Zheng F; Zhang B; Qiang L; Ren G; Song L; Bu B; Fang S; Yu B; Zhou J; Yu J; Li H
Elife; 2023 Nov; 12():. PubMed ID: 37929934
[TBL] [Abstract] [Full Text] [Related]
8. Updated Clinical Perspectives and Challenges of Chimeric Antigen Receptor-T Cell Therapy in Colorectal cancer and Invasive breast cancer.
Cao Y; Efetov SK; He M; Fu Y; Beeraka NM; Zhang J; Zhang X; Bannimath N; Chen K
Arch Immunol Ther Exp (Warsz); 2023 Aug; 71(1):19. PubMed ID: 37566162
[TBL] [Abstract] [Full Text] [Related]
9. Incidence, clinicopathological features, and clinical outcomes of low HER2 expressed, inoperable, advanced, or recurrent gastric/gastroesophageal junction adenocarcinoma.
Nakayama I; Takahari D; Chin K; Wakatsuki T; Takamatsu M; Yamamoto N; Ogura M; Ooki A; Fukuda K; Osumi H; Fukuoka S; Shinozaki E; Yamaguchi K
ESMO Open; 2023 Aug; 8(4):101582. PubMed ID: 37348349
[TBL] [Abstract] [Full Text] [Related]
10. [Biomarkers for early screening and diagnosis of breast cancer: a review].
Liang Y; Hao M; Guo R; Li X; Li Y; Yu C; Yang Z
Sheng Wu Gong Cheng Xue Bao; 2023 Apr; 39(4):1425-1444. PubMed ID: 37154315
[TBL] [Abstract] [Full Text] [Related]
11. Serum CCL7 Is a Novel Prognostic Biomarker of Metastatic Colorectal cancer.
Chidimatsu H; Tsunedomi R; Nakagami Y; Xu M; Nakajima M; Nakashima-Nakasuga C; Tomochika S; Yoshida S; Suzuki N; Watanabe Y; Matsui H; Shindo Y; Tokumitsu Y; Iida M; Takeda S; Ioka T; Ueno T; Tanabe T; Hoshii Y; Hazama S; Nagano H
Anticancer Res; 2023 Jan; 43(1):105-114. PubMed ID: 36585204
[TBL] [Abstract] [Full Text] [Related]
12. Risk Factors for Lymphovascular Invasion in Invasive Ductal Carcinoma Based on Clinical and Preoperative breast MRI Features: a Retrospective Study.
Zhang C; Liang Z; Feng Y; Xiong Y; Manwa C; Zhou Q
Acad Radiol; 2023 Aug; 30(8):1620-1627. PubMed ID: 36414494
[TBL] [Abstract] [Full Text] [Related]
13. Old and New Blood Markers in Human Colorectal cancer.
Wautier JL; Wautier MP
Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36361758
[TBL] [Abstract] [Full Text] [Related]
14. Blood Test for breast cancer Screening through the Detection of Tumor-Associated Circulating Transcripts.
Park S; Ahn S; Kim JY; Kim J; Han HJ; Hwang D; Park J; Park HS; Park S; Kim GM; Sohn J; Jeong J; Song YU; Lee H; Kim SI
Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012405
[TBL] [Abstract] [Full Text] [Related]
15. Correlation of TBK1, AR, and other serum cancer-related biomarkers in breast cancer patients: An observational study.
Liu H; Li H; Zhang J; Meng Q; Ma L
Medicine (Baltimore); 2022 Aug; 101(33):e29996. PubMed ID: 35984205
[TBL] [Abstract] [Full Text] [Related]
16. cancer-testis antigen KK-LC-1 is a potential biomarker associated with immune cell infiltration in lung adenocarcinoma.
Kang Y; Gan Y; Jiang Y; You J; Huang C; Chen Q; Xu X; Chen F; Chen L
BMC Cancer; 2022 Jul; 22(1):834. PubMed ID: 35907786
[TBL] [Abstract] [Full Text] [Related]
17. Soluble POSTN is a novel biomarker complementing CA153 and cea for breast cancer diagnosis and metastasis prediction.
Jia L; Li G; Ma N; Zhang A; Zhou Y; Ren L; Dong D
BMC Cancer; 2022 Jul; 22(1):760. PubMed ID: 35831854
[TBL] [Abstract] [Full Text] [Related]
18. Biomarker Profiling Revealed Carcinoembryonic Antigen as a Target of Artesunate in a Ductal breast cancer Patient.
Saeed MEM; Drif AI; Efferth T
Anticancer Res; 2022 Jul; 42(7):3483-3494. PubMed ID: 35790273
[TBL] [Abstract] [Full Text] [Related]
19. High serum exosomal long non-coding RNA DANCR expression confers poor prognosis in patients with breast cancer.
Shi W; Jin X; Wang Y; Zhang Q; Yang L
J Clin Lab Anal; 2022 Mar; 36(3):e24186. PubMed ID: 35150011
[TBL] [Abstract] [Full Text] [Related]
20. MOAI: a multi-outcome interaction identification approach reveals an interaction between vaspin and carcinoembryonic antigen on colorectal cancer prognosis.
Lin YD; Lee YC; Chiang CP; Moi SH; Kan JY
Brief Bioinform; 2022 Jan; 23(1):. PubMed ID: 34661627
[TBL] [Abstract] [Full Text] [Related]
[Next]
